Market Overview:
The global implantable pulse generator market is expected to grow at a CAGR of 5.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of neurovascular diseases, cardiovascular diseases, and orthopedic disorders. Additionally, the increasing demand for minimally invasive surgeries is also contributing to the growth of this market. The implantable pulse generator market is segmented by type into neurovascular diseases, cardiovascular diseases, and orthopedic disorders. The neurovascular disease segment is expected to grow at a CAGR of 6% from 2018 to 2030 due to the increasing prevalence of stroke and cerebral aneurysm. The cardiovascular disease segment is expected grow at a CAGR of 5% from 2018-2030 due increased incidence rates for heart failure and myocardial infarction (MI).
Product Definition:
An implantable pulse generator (IPG) is a device used to provide electrical stimulation to specific areas of the body. IPGs are often used to treat conditions such as chronic pain, heart failure, and epilepsy.
Neurovascular Diseases:
Neurovascular diseases are a group of conditions that involve the brain, spinal cord, and the peripheral nervous system. The neurovascular disease market is expected to grow at a significant rate owing to factors such as increasing geriatric population base coupled with rising awareness about these disorders among patients. Moreover, technological advancements in medical devices and equipment used for treatment of these disorders is also one of the growth factor for this market.
Cardiovascular Diseases:
Cardiovascular diseases (CVDs) are a group of conditions that involve the major functions of the heart and blood vessels. The most common forms of CVDs include coronary heart disease (CHD), stroke, and peripheral artery disease. According to WHO, globally CVDs contribute to 7 out 10 deaths worldwide with 17 million deaths in Europe and North America in 2012.
Application Insights:
The clinics segment held the largest share of over 70.0% in 2017. The clinics application segment includes dental care, primary healthcare centers and others such as diagnostic centers, imaging centers and urgent care clinics. The growth in these settings is attributed to an increase in the number of patients suffering from cardiac arrest or any other form of cardiac arrhythmia across all age groups that require Implantable Pulsed Generator (IPG) for immediate treatment without having to be connected to a battery source or power supply device.
The hospitals setting is expected to exhibit a lucrative CAGR during the forecast period owing to growing awareness about arrhythmia among both staff and patients as well as increasing government initiatives on improving healthcare infrastructure at global level which has resulted in increased demand for IPGs worldwide since 2016 under this application setting category.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing prevalence of CVDs, growing geriatric population, and rising adoption of advanced medical devices. In addition, high healthcare expenditure and favorable reimbursement policies are also contributing toward regional growth.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to improving healthcare infrastructure and rising demand for minimally invasive surgeries coupled with increasing prevalence of cardiovascular diseases (CVDs), orthopedic disorders, neurovascular diseases (NVDs), diabetes & obesity among others.
Europe accounted for a significant share owing to factors such as technological advancements resulting in better diagnostic facilities along with growing geriatric population prone towards chronic conditions that require long-term treatment options like implantsable pulse generator (IPG).
Growth Factors:
- Increasing geriatric population: The global implantable pulse generator market is expected to grow at a CAGR of 5.5% during the forecast period, owing to the increasing geriatric population. This is because as people age, they are more likely to suffer from various chronic diseases that require treatment with an implantable pulse generator.
- Rising prevalence of neurological disorders: The prevalence of neurological disorders such as Parkinson’s disease, epilepsy, and Alzheimer’s disease is increasing rapidly across the globe due to changing lifestyles and environmental factors. This is expected to drive the demand for implantable pulse generators in the coming years.
- Technological advancements: The development of new technologies in implantable pulse generators has led to their miniaturization and increased efficiency over traditional devices such as pacemakers and defibrillators. This is likely to boost demand for these devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Implantable Pulse Generator Market Research Report
By Type
Neurovascular Diseases, Cardiovascular Diseases, Orthopedic
By Application
Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics
By Companies
Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical, Medtronic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
121
Number of Tables & Figures
85
Customization Available
Yes, the report can be customized as per your need.
Global Implantable Pulse Generator Market Report Segments:
The global Implantable Pulse Generator market is segmented on the basis of:
Types
Neurovascular Diseases, Cardiovascular Diseases, Orthopedic
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Home Care Settings, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Boston Scientific Corporation
- Abbott
- Synapse Biomedical
- Nevro Corporation
- Neurosigma
- Neuropace
- Cyberonics
- BioControl Medical
- Medtronic
Highlights of The Implantable Pulse Generator Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Neurovascular Diseases
- Cardiovascular Diseases
- Orthopedic
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Home Care Settings
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Implantable Pulse Generator Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
An implantable pulse generator (IPG) is a medical device that generates an electric current to treat certain conditions. IPGs are inserted under the skin and connected to a battery, which powers the device. They can be used to treat heart failure, severe cardiac arrhythmias, and other conditions.
Some of the key players operating in the implantable pulse generator market are Medtronic, Boston Scientific Corporation, Abbott, Synapse Biomedical, Nevro Corporation, Neurosigma, Neuropace, Cyberonics, BioControl Medical, Medtronic.
The implantable pulse generator market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Implantable Pulse Generator Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Implantable Pulse Generator Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Implantable Pulse Generator Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Implantable Pulse Generator Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Implantable Pulse Generator Market Size & Forecast, 2020-2028
4.5.1 Implantable Pulse Generator Market Size and Y-o-Y Growth
4.5.2 Implantable Pulse Generator Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Neurovascular Diseases
5.2.2 Cardiovascular Diseases
5.2.3 Orthopedic
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Home Care Settings
6.2.4 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Implantable Pulse Generator Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Implantable Pulse Generator Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Neurovascular Diseases
9.6.2 Cardiovascular Diseases
9.6.3 Orthopedic
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Home Care Settings
9.10.4 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Neurovascular Diseases
10.6.2 Cardiovascular Diseases
10.6.3 Orthopedic
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Home Care Settings
10.10.4 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Neurovascular Diseases
11.6.2 Cardiovascular Diseases
11.6.3 Orthopedic
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Home Care Settings
11.10.4 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Neurovascular Diseases
12.6.2 Cardiovascular Diseases
12.6.3 Orthopedic
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Home Care Settings
12.10.4 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Neurovascular Diseases
13.6.2 Cardiovascular Diseases
13.6.3 Orthopedic
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Home Care Settings
13.10.4 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Implantable Pulse Generator Market: Competitive Dashboard
14.2 Global Implantable Pulse Generator Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Medtronic
14.3.2 Boston Scientific Corporation
14.3.3 Abbott
14.3.4 Synapse Biomedical
14.3.5 Nevro Corporation
14.3.6 Neurosigma
14.3.7 Neuropace
14.3.8 Cyberonics
14.3.9 BioControl Medical
14.3.10 Medtronic
